Assure Sets Managed Cases Record for Full-Year, Fourth Quarter and Month of December 2021
Assure Holdings Corp. (NASDAQ: IONM) reported record growth in its managed cases for 2021, achieving approximately 17,400 cases, a 75% increase from 2020. This included over 5,000 cases in Q4 and 1,900 in December. Despite challenges from COVID-19, the company aims to exceed 25,000 managed cases in 2022, signaling a projected growth of more than 40%. The company provides intraoperative neuromonitoring services, highlighted by its recognition for high patient care standards.
- Record managed cases in 2021: approximately 17,400, up 75% from 2020.
- Achieved over 5,000 managed cases in Q4 2021.
- Aiming for more than 25,000 managed cases in 2022, suggesting growth of over 40%.
- Ongoing impact of COVID-19 may hinder managed case volume growth.
- Expansion efforts in some markets slowed due to the pandemic.
DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced an annual, quarterly and monthly record for managed cases in the full-year period, the fourth quarter and the month of December 2021.
John A. Farlinger, executive chairman and CEO said, “The Company reported our highest number of managed cases in the full-year period, the fourth quarter and the month of December 2021. In 2021, Assure performed approximately 17,400 managed cases, exceeding our full-year forecast. This total included more than 5,000 managed cases in the fourth quarter of 2021 and over 1,900 in the month of December. Comparatively, in 2020, we performed over 9,900 managed cases during the full year, including more than 3,000 in the fourth quarter and nearly 1,100 in December 2020.”
Farlinger continued, “Although we continue to experience a limited impact on our managed case volume as a result of COVID-19 and acknowledge that the pandemic has slowed our expansion efforts in certain markets, Assure is pleased to have grown its total managed cases by more than
Farlinger concluded, “Looking forward, we continue to expect to grow our managed case volume to more than 25,000 managed cases in 2022 despite the lingering impact of COVID-19, representing a potential increase of more than
About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles
Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: growing the Company’s managed case volume in 2022 and expected managed case volume from other sources including potential M&A activity and new business wins. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the Company may not grow its managed case volume to more than 25,000 managed cases in 2022; the Company may not generate managed case volume from potential M&A activity or new business associated with its agreement with Premier Inc.; the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, including but not limited to managed case volumes, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 30, 2021, and with the Canadian securities regulators and available on the Company’s profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Key Performance Metrics
This announcement contains the key performance metric, managed cases, that management of the Company utilizes to determine operational performance from period to period. A managed case is all technical cases Assure performs and any cases where the professional bill is from a
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
Scott.Kozak@assureiom.com
FAQ
What were Assure Holdings' managed cases for 2021?
How many managed cases did Assure Holdings have in Q4 2021?
What is Assure Holdings' growth forecast for managed cases in 2022?
What impact did COVID-19 have on Assure Holdings' operations?
